RxDoctor Payments Data

James Day

Pediatric Infectious Diseases · Kansas City, MONPI 1508823006

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, GSK. That places this record below the midpoint for pediatric infectious diseases clinicians in MO, where the typical reported total is $31.

$31in general payments, 2019–2025

Across 2 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$31
$1,315,146in research payments, 2019–2025

Across 159 payments — averaging $8271.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.1M
  • Astellas Pharma Global Development$223K
  • Astellas US Technologies$19K

What the payments were for

  • Food & beverage$31100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK2$31

How this compares

$31 in reported general payments places this provider in the 50th percentile of 26 pediatric infectious diseases providers in Missouri.

See all pediatric infectious diseases providers in Missouri →

Other pediatric infectious diseases in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →